Pegasys /RBV

DRUG2 trials

Sponsors

Beijing Kawin Technology Share-Holding Co., Ltd.

Conditions

Chronic Hepatitis CChronic Hepatitis c

Phase 2

A Phase Ⅱ Dose-escalating Study of PEG-IFN-SA and Ribavirin in IFN Naive Patients With Chronic Hepatitis C

CompletedNCT01908335

Beijing Kawin Technology Share-Holding Co., Ltd.Chronic Hepatitis C

Start: 2012-10-31End: 2014-07-31Updated: 2014-10-20

Phase 3

Efficacy and Safety Study of PEG-IFN-SA and Ribavirin to Treat Chronic Hepatitis C

CompletedNCT01903278

Beijing Kawin Technology Share-Holding Co., Ltd.Chronic Hepatitis c

Start: 2013-06-30End: 2015-08-31Updated: 2015-09-25